Toronto Dominion Bank Invests $24.88 Million in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Toronto Dominion Bank acquired a new position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 540,024 shares of the company’s stock, valued at approximately $24,879,000. Toronto Dominion Bank owned about 1.93% of Establishment Labs as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. Quarry LP acquired a new stake in shares of Establishment Labs during the fourth quarter worth $27,000. R Squared Ltd acquired a new stake in shares of Establishment Labs during the fourth quarter worth $36,000. Federated Hermes Inc. boosted its holdings in shares of Establishment Labs by 3.0% during the fourth quarter. Federated Hermes Inc. now owns 32,720 shares of the company’s stock worth $1,507,000 after purchasing an additional 953 shares during the last quarter. Swiss National Bank boosted its holdings in shares of Establishment Labs by 2.7% during the fourth quarter. Swiss National Bank now owns 38,500 shares of the company’s stock worth $1,774,000 after purchasing an additional 1,000 shares during the last quarter. Finally, Handelsbanken Fonder AB raised its position in shares of Establishment Labs by 32.3% in the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company’s stock worth $378,000 after buying an additional 2,000 shares during the period. Institutional investors and hedge funds own 72.91% of the company’s stock.

Establishment Labs Trading Up 0.8%

NASDAQ:ESTA opened at $36.90 on Wednesday. The business’s 50-day moving average is $34.21 and its two-hundred day moving average is $37.73. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. Establishment Labs Holdings Inc. has a 12 month low of $26.56 and a 12 month high of $58.00. The firm has a market capitalization of $1.07 billion, a PE ratio of -14.30 and a beta of 0.73.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings data on Wednesday, May 7th. The company reported ($0.70) EPS for the quarter, beating the consensus estimate of ($0.83) by $0.13. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The company had revenue of $41.38 million for the quarter, compared to analyst estimates of $41.15 million. During the same period last year, the company posted ($0.58) earnings per share. The firm’s revenue was up 11.3% compared to the same quarter last year. Research analysts predict that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on ESTA shares. Needham & Company LLC raised Establishment Labs from a “hold” rating to a “buy” rating and set a $48.00 target price on the stock in a research report on Wednesday, May 14th. Wall Street Zen lowered Establishment Labs from a “hold” rating to a “sell” rating in a research report on Thursday, May 22nd. BTIG Research started coverage on Establishment Labs in a research report on Friday, May 16th. They issued a “buy” rating and a $62.00 target price on the stock. Finally, Stephens reaffirmed an “overweight” rating and issued a $52.00 target price on shares of Establishment Labs in a research report on Thursday, March 6th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $55.33.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.